Schedule 13D ownership disclosure
SILEXION THERAPEUTICS CORP
Ordinary Shares, par value $0.0009 per share · CUSIP: G1281K122
Event date: 2025-06-26
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Wildcat Capital Management, LLCReported CIK 0001582384
Shares: 113,428 · Class: 1.3%
- Wildcat Partner Holdings, LPReported CIK 0001633223
Shares: 113,428 · Class: 1.3%
- Leonard A. PotterReported CIK 0001476217
Shares: 113,428 · Class: 1.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-090404
- Form type
- SCHEDULE 13D/A
- Filer
- Silexion Therapeutics Corp
- CIK
- CIK 2022416
- Filed
- Jun 26, 2025
- Reporting period
- Jun 26, 2025
- Description
- Schedule 13D beneficial ownership